A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
Gynecologic Oncology | Feb 01, 2019
Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse
Menopause | Feb 01, 2019
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort
Prostate Cancer & Prostatic Diseases | Feb 01, 2019
MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
OncoTargets and Therapy | Feb 01, 2019
Efficacy and safety of nivolumab for metastatic biliary tract cancer
OncoTargets and Therapy | Feb 01, 2019
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India
International Journal of Rheumatic Diseases | Feb 01, 2019
Pregabalin as adjunctive treatment for focal onset seizures in pediatric patients: A randomized controlled trial
Journal of Child Neurology | Feb 01, 2019